Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2023 16:03 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Reports Third Quarter 2023 Financial Results

SANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment...
November 06, 2023 07:00 ET | Source: TScan Therapeutics, Inc.

TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting

Solid tumor program uses separate screening protocol designed to identify patients in advance of treatment protocol; on track to enroll first patient in study this year Company adds TSC-201-B0702 to...
November 03, 2023 12:03 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months

Company builds on deep structure-based drug design capabilities to add protein therapeutics to pipeline: BCX17725 for Netherton syndrome — entering clinic in 2H 2024Bifunctional fusion protein...
November 02, 2023 16:00 ET | Source: Kratos Defense & Security Solutions, Inc.

Kratos Reports Third Quarter 2023 Financial Results

Third Quarter 2023 Revenues of $274.6 Million Reflect 20.1 Percent Organic Growth Over Third Quarter 2022 Revenues of $228.6 Million Third Quarter 2023 Revenues Reflect 22.0 Percent...
November 02, 2023 05:00 ET | Source: Visiongain Reports Ltd

Command and Control (C2) System market is projected to grow at a CAGR of 6.4% by 2034: Visiongain

Visiongain has published a new report entitled Command and Control (C2) System Market Report 2024-2034: Forecasts by Component (Hardware, Software), by Software (Command and Control Software,...
October 31, 2023 02:00 ET | Source: argenx SE

argenx Reports Third Quarter 2023 Financial Results and Provides Business Update

$329 million in third quarter global net product salesOn track to submit VYVGART® Hytrulo sBLA for CIDP by year-end 2023 Results from the ADVANCE-IV study published in The Lancet Management to host...
October 24, 2023 10:45 ET | Source: Janssen EMEA

Los Primeros Resultados Con El Sistema De Administración Intravesical Liberador De Erdafitinib (TAR-210) Muestran Evidencias Tempranas De Actividad Clínica Positiva En Pacientes Con Cáncer De Vejiga No Músculo Invasivo Con Alteraciones Seleccionadas Del Receptor Del Factor De Crecimiento De Fibroblastos

Los primeros resultados en humanos de TAR-210 en fase de investigación ponen de manifiesto el potencial de la liberación local sostenida de erdafitinib con un novedoso sistema de administración...
October 24, 2023 10:41 ET | Source: Janssen EMEA

Les Premiers Résultats Obtenus Avec Le Système D’administration Intravésicale D’erdafitinib (TAR-210) Montrent Des Signes Précoces D’activité Clinique Positive Chez Des Patients Atteints De Cancer De La Vessie N’infiltrant Pas Le Muscle Et Présentant Des Altérations Du Récepteur Du Facteur De Croissance Des Fibroblastes

Les résultats de l’étude TAR-210 menée pour la première fois chez l’homme mettent en évidence le potentiel de libération locale prolongée de l’erdafitinib grâce à un nouveau système d’administration...
October 22, 2023 04:35 ET | Source: Janssen Pharmaceutica NV

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery system.1 Phase 1 results show a manageable safety...
October 20, 2023 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Introduces Enhanced Coronary IVL Catheter in the United States

Shockwave C2+ Debut Joins Packed Shockwave Agenda at Transcatheter Cardiovascular Therapeutics Conference in San Francisco SANTA CLARA, Calif., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave...